IP Library Granted Patent US 12,251,496
Granted Patent B2
US 12,251,496 · App. 16/426,099 · Granted Mar 18, 2025

Wavy multi-component vascular grafts with biomimetic mechanical properties, antithrombogenicity, and endothelial cell affinity

Inventors: Lih-Sheng Turng (Madison, WI); Hao-Yang Mi (Madison, WI)
Assignee: Wisconsin Alumni Research Foundation
A61L27/507A61F2/06A61L27/18A61L27/20A61L27/24A61L27/26A61L27/3808A61L27/3826A61L27/3834A61L27/3886A61L27/48B32B5/26D01D5/0007A61F2210/0076A61F2240/001
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,251,496
App. No.
16/426,099
Granted
Mar 18, 2025
Kind
B2
Abstract

Disclosed herein are novel wavy, multi-component vascular grafts (WMVGs) with a wavy inner layer of rigid biopolymer fibers and an outer layer of elastic biopolymer fibers and a method for preparing WMVGs via electrospinning using a special assembled collector. The fabricated WMVGs closely mimic the non-linear tensile stress-strain relationship of native blood vessels and showed sufficient mechanical strength needed for implantation.

Claims (26)

1. A wavy multi-component vascular graft comprising an inner layer comprising

rigid polymer fibers comprising silk and poly (lactic acid) (PLA)-and an outer layer comprising elastic polymer fibers selected from the group consisting of thermoplastic polyurethane (TPU), polyglycerol sebacate (PGS), poly (ester urethane) urea (PEUU), and combinations thereof;

wherein the outer layer provides the outermost surface of the wavy multicomponent vascular graft.

2. The wavy multi-component vascular graft of claim 1 wherein the rigid polymer fibers comprise submicron diameter fibers.

3. The wavy multi-component vascular graft of claim 1 wherein the rigid polymer fibers comprise an average fiber diameter ranging from about 100 nm to about 1000 nm.

4. The wavy multi-component vascular graft of claim 1 wherein the elastic polymer fibers comprise nanoscale diameter fibers and submicron diameter fibers.

5. The wavy multi-component vascular graft of claim 1 wherein the elastic polymer fibers comprise an average fiber diameter ranging from about 50 nm to about 300 nm.

6. The wavy multi-component vascular graft of claim 1 further comprising a biomolecule.

7. The wavy multi-component vascular graft of claim 1 further comprising a cell.

8. The wavy multi-component vascular graft of claim 1 comprising a lumen diameter less than 6 mm.

9. The wavy multi-component vascular graft of claim 1 comprising a wall thickness ranging from about 200 μm to about 500 μm.

10. The wavy multi-component vascular graft of claim 1 comprising a suture retention strength ranging from about 1 N to about 4 N.

11. A method for preparing the wavy multi-component vascular graft of claim 1 , the method comprising:

electrospinning a first solution comprising a water soluble polymer material to form a first water soluble fiber;

collecting the first water soluble fiber on an assembled mandrel that comprises a central tube and a plurality of satellite cylinders surrounding the tube to form a first water soluble fiber layer;

electro-spinning a second solution comprising a rigid polymer material comprising PLA and silk to form a second fiber;

collecting the second fibers on the first water soluble fiber layer to form an inner rigid polymer fiber layer;

electrospinning a third solution comprising an elastic polymer material comprising TPU, PGS, PEUU or a combination thereof to form a third fiber;

collecting the third fibers on the rigid polymer fiber layer on the assembled mandrel to form an outer elastic polymer fiber layer; and

removing the assembled mandrel to form a wavy multi-component vascular graft.

12. The method of claim 11 further comprising removing the water soluble fiber layer.

13. The method of claim 11 wherein the second solution and the third solution have a volume ratio ranging from about 1:2 to about 2:1.

14. The method of claim 11 , wherein the inner rigid polymer fiber layer is modified with a biomolecule.

15. The method of claim 14 , wherein the biomolecule is selected from the group consisting of dopamine, heparin, cell adhesion molecules, growth factors, chemokines, anti-coagulants, and combinations thereof.

16. The method of claim 11 further comprising seeding a cell on the wavy multi-component vascular graft.

17. The method of claim 16 , wherein the cell is selected from the group consisting of an endothelial cell, a smooth muscle cell, a mesenchymal stem cell, a fibroblast cell, and combinations thereof.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jun 4, 2019
From: UNIVERSITY OF WISCONSIN MADISON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 049355/0781 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 3, 2019
From: MI, HAOYANG; TURNG, LIH-SHENG
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 049345/0235 →
Continuity (2)
Provisional Application 62677931 · May 30, 2018
Related Publication 20190365953A1 · Dec 5, 2019
References Cited (28)
US 3878565A · Sauvage · 1975 [cited by applicant]
US 4892539A · Koch · 1990 [cited by applicant]
US 9593199B2 · Wamprecht · 2017 [cited by examiner]
US 20060129234A1 · Phaneuf · 2006 [cited by examiner]
US 20160302911A1 · Soletti · 2016 [cited by applicant]
US 20170173226A1 · Hai et al. · 2017 [cited by applicant]
WO 2016187698A1 · 2016 [cited by applicant]
WO 2018053265A1 · 2018 [cited by applicant]
Zhang et al. Biofabrication 2017 9(2):025010, 1-14 (Year: 2017). [cited by examiner]
Bae et al. International Journal of Industrial Entomology 2016 33(2):132-137 (Year: 2016). [cited by examiner]
Liu et al. Journal of Materials Chemistry B 2017 5:3758-3764 (Year: 2017). [cited by examiner]
Sigma reference—product specification sheet for CAS No. 68084-39-9 (Year: 2011). [cited by examiner]
Liu et al. BioMed Central Cardiovascular Disorders 2013 13(70):1-7 (Year: 2013). [cited by examiner]
Uttayarat et al. Acta Biomaterialia 2010 6:4229-4237 (Year: 2010). [cited by examiner]
Wang et al. Frontiers of Chemical Science and Engineering 2011 5(3):392-400 (Year: 2011). [cited by examiner]
Mi et al. Journal of the Mechanical Behavior of Biomedical Materials 2018 78:433-441—available Dec. 1, 2017 (Year: 2018). [cited by examiner]
Sankaran et al. Biotechnology Journal 2015 10:96-108 (Year: 2018). [cited by examiner]
Zhang et al. Journal of Biomedical Materials Research 2010 93A: 984-993 (Year: 2010). [cited by examiner]
Yin et al. Colloids and Surfaces B: Biointerfaces 2014 120:47-54 (Year: 2014). [cited by examiner]
Uttayarat et al. Journal of Biomedical Materials Research 2005 75A:668-680 (Year: 2005). [cited by examiner]
Jiang et al. Langmuir 2002 18: 3273-3280 (Year: 2002). [cited by examiner]
Zhang et al. Polymer Composites 2016 37(2):523-531 (Year: 2016). [cited by examiner]
Williamson et al. Biomaterials 2006 27:3608-3616 (Year: 2006). [cited by examiner]
Khosravi et al. Annals of Biomedical Engineering 2016 44(8): 2402-2416 (Year: 2016). [cited by examiner]
Ravi et al., Biomaterials for vascular tissue engineering; Regen Med., 2010, vol. 5, No. 1, 21 pages. [cited by applicant]
Mi et al., Promoting Endothelial Cell Affinity and Antithrombogenicity of Polytetrafluoreothylene (PTFE) by Mussel-Inspired Modification and RGD/Heparin Grafting; J. Mater Chem B; 2018, vol. 6, pp. 3475-3485. [cited by applicant]
Yu et al., Development of Biomimetic Thermoplastic Polyurethane/Fibroin Small-Diameter Vascular Grafts via a Novel Electrospinning Approach; J. Biomed Mater Res A.; 2018; vol. 106, No. 4. pp. 985-996. [cited by applicant]
Singh, C., Wong, C. S. & Wang, X. Medical Textiles as Vascular Implants and Their Success to Mimic Natural Arteries. J Funct Biomater 6, 500-525, doi:10.3390/jfb6030500 (2015). [cited by applicant]